SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-246378
Filing Date
2022-09-16
Accepted
2022-09-16 16:15:57
Documents
15
Period of Report
2022-09-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d359932d8k.htm   iXBRL 8-K 57326
2 EX-3.1 d359932dex31.htm EX-3.1 5768
3 EX-3.2 d359932dex32.htm EX-3.2 9367
4 EX-99.1 d359932dex991.htm EX-99.1 16953
  Complete submission text file 0001193125-22-246378.txt   236288

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA syrs-20220915.xsd EX-101.SCH 2852
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20220915_lab.xml EX-101.LAB 18741
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20220915_pre.xml EX-101.PRE 11705
9 EXTRACTED XBRL INSTANCE DOCUMENT d359932d8k_htm.xml XML 3567
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37813 | Film No.: 221248249
SIC: 2834 Pharmaceutical Preparations